Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Effectiveness of Blue Code Team After In-hospital Cardiopulmonary Arrest (Codeblue)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03378518
Recruitment Status : Completed
First Posted : December 20, 2017
Last Update Posted : December 21, 2017
Sponsor:
Information provided by (Responsible Party):
SİNAN YILMAZ, Aydin Adnan Menderes University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 2016-2017.

Primary outcome: an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2016-2017.

Secondary outcome: to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.


Condition or disease
In-hospital Cardiac Arrest

Detailed Description:

This study aimed to retrospectively examine patients evaluated by the Code Blue team on a Code Blue call in our hospital between 20016 and 2017.

Primary outcome: an examination of the survival rates and demographic data of the patients evaluated as an emergency by a Code Blue call in the period 2016-2017.Secondary outcome: to determine the rates of false Code Blue calls, the clinics giving Code Blue calls and the relationship between the times of Code Blue calls and mortality.Inclusion criteria: patients throughout the whole hospital for whom a Code Blue form was completed and who were evaluated by the Code Blue team on a Code Blue call.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 264 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: Evaluation of Effectiveness of Blue Code Team After In-hospital Cardiopulmonary Arrest
Actual Study Start Date : January 1, 2016
Actual Primary Completion Date : December 31, 2016
Actual Study Completion Date : July 1, 2017

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Blue code notification form [ Time Frame: 12 month ]
    Survival rate of patients intervened by blue code team after in-hospital cardiac arrest


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients who were coded blue due to in-hospital cardiac arrest between January 1, 2016 and December 31, 2016.
Criteria

Inclusion criteria:

-Patients intervened by code blue team

Exclusion criteria:

  • Cardiac arrest in the anesthesiology and reanimation intensive care unit
  • Cardiac arrest in the newborn intensive care unit
  • Out-of-hospital cardiac arrest
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03378518


Locations
Layout table for location information
Turkey
Adnan Menderes University Training and Research Hospital
Aydın, Turkey, 09100
Sponsors and Collaborators
Aydin Adnan Menderes University
Investigators
Layout table for investigator information
Principal Investigator: sinan yılmaz Aydin Adnan Menderes University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: SİNAN YILMAZ, Assistant Professor, Aydin Adnan Menderes University
ClinicalTrials.gov Identifier: NCT03378518    
Other Study ID Numbers: Codeblue
First Posted: December 20, 2017    Key Record Dates
Last Update Posted: December 21, 2017
Last Verified: November 2017

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by SİNAN YILMAZ, Aydin Adnan Menderes University:
In-hospital Cardiac Arrest, mortality
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Arrest
Heart Diseases
Cardiovascular Diseases